Abstract
Radionuclide imaging techniques either using positron emission tomography (PET) or single-photon emission computed tomography (SPECT) are among the most established for the detection of viable myocardium. They offer the advantage of highest sensitivity, but are just moderately specific for the prediction of postrevascularization functional recovery. The disappointing results of various recent randomized trials have questioned the advantages of coronary revascularization in patients with ischemic cardiomyopathy and raised doubts about the helpfulness of viability imaging. Nevertheless, the increasing number of patients that come to medical attention because of heart failure symptoms supports the use of imaging modalities to recognize the underlying disease and, in case of coronary artery disease, to evaluate its extent and severity. In this scenario, radionuclide techniques have the advantage of allowing the recognition of inducible ischemia as well as myocardial viability, and will thus, remain an important tool for the work up of these patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.